SCFAs, final products of dietary ingredients fermented by gut microbiota (Canfora et al., 2015), have been unveiled to prevent metabolic endotoxemia, protect against inflammation, increase insulin sensitivity, enhance intestinal barrier function, and prevent diet-induced obesity (You et al., 2022). This evidence concerns the gene INS and obesity disorder.